High-dose vs approved-dose fulvestrant for ER+ breast cancer
- 3 Downloads
KeywordsBreast Cancer Estrogen Postmenopausal Woman Labelling Index Evaluable Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2008